This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1998 Jun;86(6):1207-9.

doi: 10.1097/00000539-199806000-00012.

Vasopressin for the treatment of refractory hypotension after cardiopulmonary bypass

P T Overand¹, J F Teply

Affiliations

PMID: 9620504
DOI: 10.1097/00000539-199806000-00012

Case Reports

Vasopressin for the treatment of refractory hypotension after cardiopulmonary bypass

P T Overand et al. Anesth Analg. 1998 Jun.

. 1998 Jun;86(6):1207-9.

doi: 10.1097/00000539-199806000-00012.

Authors

P T Overand¹, J F Teply

Affiliation

¹ Department of Cardiac Anesthesiology, Providence Medical Center, Seattle, Washington, USA.

PMID: 9620504
DOI: 10.1097/00000539-199806000-00012

No abstract available

PubMed Disclaimer

Comment in

Vasopressin and postcardiopulmonary bypass refractory hypotension.
Licker M, Schweizer A. Licker M, et al. Anesth Analg. 1999 Mar;88(3):695. doi: 10.1097/00000539-199903000-00054. Anesth Analg. 1999. PMID: 10072037 No abstract available.

Similar articles

Vasopressin for refractory hypotension during cardiopulmonary bypass.
Talbot MP, Tremblay I, Denault AY, Bélisle S. Talbot MP, et al. J Thorac Cardiovasc Surg. 2000 Aug;120(2):401-2. doi: 10.1067/mtc.2000.107208. J Thorac Cardiovasc Surg. 2000. PMID: 10917960 No abstract available.
The use of a somatostatin analog in the treatment of refractory hypotension after cardiopulmonary bypass.
Egener TH, Comunale ME, Leckie RS. Egener TH, et al. J Cardiothorac Vasc Anesth. 1992 Aug;6(4):458-60. doi: 10.1016/1053-0770(92)90015-y. J Cardiothorac Vasc Anesth. 1992. PMID: 1498303 No abstract available.
Vasopressin for treatment of shock following aprotinin administration.
Williams SR, Denault AY, Pellerin M, Martineau R. Williams SR, et al. Can J Anaesth. 2004 Feb;51(2):169-72. doi: 10.1007/BF03018778. Can J Anaesth. 2004. PMID: 14766695
Low systemic vascular resistance during cardiac surgery: case reports, brief review, and management with angiotensin II.
Thaker U, Geary V, Chalmers P, Sheikh F. Thaker U, et al. J Cardiothorac Anesth. 1990 Jun;4(3):360-3. doi: 10.1016/0888-6296(90)90046-i. J Cardiothorac Anesth. 1990. PMID: 2131886 Review. No abstract available.
[Vasoplegic syndrome and its treatment with vasopressin during cardiac surgery with cardiopulmonary bypass].
Gilbert M, Lema G. Gilbert M, et al. Rev Med Chil. 2011 Mar;139(3):368-72. Epub 2011 Aug 25. Rev Med Chil. 2011. PMID: 21879171 Review. Spanish.

See all similar articles

Cited by

Role of vasopressin in the management of septic shock.
Mutlu GM, Factor P. Mutlu GM, et al. Intensive Care Med. 2004 Jul;30(7):1276-91. doi: 10.1007/s00134-004-2283-8. Epub 2004 Apr 21. Intensive Care Med. 2004. PMID: 15103461 Review.
Management of vasodilatory shock: defining the role of arginine vasopressin.
Dunser MW, Wenzel V, Mayr AJ, Hasibeder WR. Dunser MW, et al. Drugs. 2003;63(3):237-56. doi: 10.2165/00003495-200363030-00001. Drugs. 2003. PMID: 12534330 Review.
New evidence for old therapies in catecholamine-dependent septic shock.
Friedrich JO, Lapinsky SE. Friedrich JO, et al. Intensive Care Med. 2001 Apr;27(4):787-90. doi: 10.1007/s001340100866. Intensive Care Med. 2001. PMID: 11398711 Review. No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- MedlinePlus Health Information